Evidence map›Paper›PMID 40693061›Full record

ArticleCureus2025

ZAP-X: An Innovative Radiosurgical Solution for Glomus Jugulare Tumors.

Chengcheng Wang, Jinyuan Wang, Jingmin Bai, Longsheng Pan, Pengfei Xu, Baolin Qu, Xiangkun Dai

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chengcheng WangDepartment of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Jinyuan WangDepartment of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Jingmin BaiDepartment of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Longsheng PanDepartment of Neurosurgery, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Pengfei XuDepartment of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Baolin QuDepartment of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Xiangkun DaiDepartment of Radiotherapy, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the clinical benefit of the application of the ZAP-X stereotactic radiosurgery (SRS) system in the treatment of glomus jugulare tumors. Two patients with recurrent or progressive glomus jugulare tumors underwent treatment with the ZAP-X SRS system. Analysis of clinical treatment processes and follow-up data over a period of up to three years revealed that after treatment with the ZAP-X system, the tumor volumes significantly reduced, and no severe radiation therapy-related complications were observed. These findings highlight the potential clinical benefits of the ZAP-X system in the treatment of complex skull base tumors.

Indexed as

dosimetric comparisonglomus jugulare tumorlong-term follow-upstereotactic radiosurgeryzap-x

Identifiers

PMID40693061
PMCPMC12279319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.